Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-30

Clinical Trial Update: Is Left Stellate Ganglionectomy Beneficial to Patients With Life Threatening Ventricular Arrhythmias [NA]

View source ↗

Summary

A clinical trial investigating left stellate ganglionectomy for life-threatening ventricular arrhythmias related to sudden cardiac death has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cindy Hall | Conditions: Sudden Cardiac Death | NA | Status: WITHDRAWN